Press releases
Spineway 2023 Financial Calendar
SPINEWAY (ISIN : FR0011398874 – ALSPW), a specialist in innovative implants for the treatment of severe spine pathologies, announced today its 2023 financial calendar.
GMED approval for new production line dedicated to ESP prosthèses / First production of LP-ESP intervertebral disc prostheses
Spineway, a specialist in innovative implants for the treatment of severe spine disorders, announces that its subsidiary Spine Innovations has received GMED (French notified body) approval for its new production line dedicated to its LP-ESP and CP-ESP intervertebral disc prostheses. This approval is a significant strategic milestone for the Group, ensuring the manufacturing and supply of its innovative ESP prostheses.
Press releases